Skip to main content

Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection

Journal of Gastroenterology volume 46, pages 487–491 (2011)Cite this article

Abstract

Background

Most monoclonal antibody-based stool antigen tests are of the “send-out” format. Rapid Testmate pylori antigen (Rapid TPAg) uses monoclonal antibody and is an “in-the-office” test. The aim of this study was to examine the usefulness of Rapid TPAg for the management of H. pylori infection.

Methods

One-hundred and two consecutive patients who received H. pylori eradication therapy underwent both urea breath test (UBT) and Rapid TPAg at 5–6 weeks after finishing the eradication therapy. Stool samples were maintained at −20, 5, 25, and 40°C and subjected to Rapid TPAg after 1–7 days. Stool samples were also tested by enzyme immunoassay (EIA) to quantify antigenicity.

Results

The agreement between Rapid TPAg and UBT in the evaluation of the results of H. pylori eradication treatment was 94.1%. The overall accuracy of Rapid TPAg and UBT to determine H. pylori eradication was 98.0 and 96.0%, respectively. The results of Rapid TPAg were not altered after storage of samples at −20 to 40°C for 7 days. Antigenicity quantified by EIA did not decrease significantly after 7 days.

Conclusions

Rapid TPAg is a useful diagnostic test for immediate and accurate determination of the results of H. pylori eradication therapy. The antigenicity of stool sample suspensions was preserved for 7 days in the collection devices.

This is a preview of subscription content, access via your institution.

Access options

Buy single article

Instant access to the full article PDF.

USD 39.95

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Fig. 1
Fig. 2

References

  1. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, et al. Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter. 2010;15:1–20.

    PubMed  Article  CAS  Google Scholar 

  2. Asaka M, Kato M, Graham DY. Prevention of gastric cancer by Helicobacter pylori eradication. Intern Med. 2010;49:633–6.

    PubMed  Article  Google Scholar 

  3. Suzuki N, Wakasugi M, Nakaya S, Kokubo N, Sato M, Kajiyama H, et al. Catalase, a specific antigen in the feces of human subjects infected with Helicobacter pylori. Clin Diagn Lab Immunol. 2002;9:784–8.

    PubMed  CAS  Google Scholar 

  4. Suzuki N, Wakasugi M, Nakaya S, Okada K, Mochida R, Sato M, et al. Production and application of new monoclonal antibodies specific for a fecal Helicobacter pylori antigen. Clin Diagn Lab Immunol. 2002;9:75–8.

    PubMed  CAS  Google Scholar 

  5. Shimoyama T, Kato C, Kodama M, Kobayashi I, Fukuda Y. Applicability of a monoclonal antibody-based stool antigen test to evaluate the results of Helicobacter pylori eradication therapy. Jpn J Infect Dis. 2009;62:225–7.

    PubMed  Google Scholar 

  6. Deguchi R, Matsushima M, Suzuki T, Mine T, Fukuda R, Nishina M, et al. Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection after eradication therapy. J Gastroenterol. 2009;44:713–6.

    PubMed  Article  CAS  Google Scholar 

  7. Cardenas VM, Dominguez DC, Puentes FA, Aragaki CC, Goodman KJ, Graham DY, et al. Evaluation of a novel stool native catalase antigen test for Helicobacter pylori infection in asymptomatic North American children. J Pediatr Gastroenterol Nutr. 2008;46:399–402.

    PubMed  Article  CAS  Google Scholar 

  8. Kato C, Sugiyama T, Sato K, Saito S, Kudara N, Abiko Y, et al. Appropriate cut-off value of 13C-urea breath test after eradication of Helicobacter pylori infection in Japan. J Gastroenterol Hepatol. 2003;18:1379–83.

    PubMed  Article  Google Scholar 

  9. Dominguez J, Forne M, Blanco S, Prat C, Gali N, Latorre I, et al. Comparison of a monoclonal with a polyclonal antibody-based enzyme immunoassay stool test in diagnosing Helicobacter pylori infection before and after eradication therapy. Aliment Pharmacol Ther. 2006;23:1735–40.

    PubMed  Article  CAS  Google Scholar 

  10. Kato M, Saito M, Fukuda S, Kato C, Ohara S, Hamada S, et al. 13C-urea breath test, using a new compact nondispersive isotope-selective infrared spectrophotometer: comparison with mass spectrometry. J Gastroenterol. 2004;39:629–34.

    PubMed  Google Scholar 

  11. Blanco S, Forné M, Lacoma A, Prat C, Cuesta MA, Fuenzalida L, et al. Evaluation of a latex agglutination test (PYLOGEN) for the detection of Helicobacter pylori in stool specimens. Diagn Microbiol Infect Dis. 2009;63:349–53.

    PubMed  Article  CAS  Google Scholar 

  12. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomized controlled trial. Lancet. 2008;372:392–7.

    PubMed  Article  Google Scholar 

  13. Adamopoulos AB, Stergiou GS, Sakizlis GN, Tiniakos DG, Nasothimiou EG, Sioutis DK, et al. Diagnostic value of rapid urease test and urea breath test for Helicobacter pylori detection in patients with Billroth II gastrectomy: a prospective controlled trial. Dig Liver Dis. 2009;41:4–8.

    PubMed  Article  CAS  Google Scholar 

  14. Yan J, Yamaguchi T, Odaka T, Suzuki T, Ohyama N, Hara T, et al. Stool antigen test is a reliable method to detect Helicobacter pylori in the gastric remnant after distal gastrectomy for gastric cancer. J Clin Gastroenterol. 2010;44:73–4.

    PubMed  Article  Google Scholar 

Download references

Acknowledgments

The authors thank Drs. Masami Sato and Ryoki Takahashi for their technical help and effective advice during the preparation of the manuscript.

Author information

Authors and Affiliations

  1. Department of Gastroenterology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan

    Tadashi Shimoyama, Manabu Sawaya, Norihiro Hanabata, Tetsuro Yoshimura & Shinsaku Fukuda

  2. Department of Medical Oncology, Hirosaki University Graduate School of Medicine, 5 Zaifu-cho, Hirosaki, 036-8562, Japan

    Atsushi Ishiguro

Authors
  1. Tadashi Shimoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Manabu Sawaya
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Atsushi Ishiguro
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Norihiro Hanabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tetsuro Yoshimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinsaku Fukuda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tadashi Shimoyama.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Shimoyama, T., Sawaya, M., Ishiguro, A. et al. Applicability of a rapid stool antigen test, using monoclonal antibody to catalase, for the management of Helicobacter pylori infection. J Gastroenterol 46, 487–491 (2011). https://doi.org/10.1007/s00535-011-0371-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00535-011-0371-4

Keywords

  • Helicobacter pylori
  • Stool antigen test
  • Eradication